Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer’s Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study

Mikkel Pejstrup Agger*, Else Rubæk Danielsen, Marcus Schultz Carstensen, N. Mai Nguyen, Maibritt Horning, Mark Alexander Henney, Christopher Boe Ravn Jensen, Anders Ohlhues Baandrup, Troels Wesenberg Kjaer, Kristoffer Hougaard Madsen, Kamilla Woznica Miskowiak, Paul Michael Petersen, Peter Høgh

*Corresponding author for this work

Research output: Contribution to journal › Journal article › Research › peer-review

436 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer’s Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study'. Together they form a unique fingerprint.

Keyphrases